Arthur F. Ryan - Nov 1, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Stock symbol
REGN
Transactions as of
Nov 1, 2021
Transactions value $
-$64,252
Form type
4
Date filed
11/3/2021, 04:11 PM
Previous filing
Oct 4, 2021
Next filing
Dec 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$3.83K -6 -0.03% $638.62 23.2K Nov 1, 2021 Direct F1, F2
transaction REGN Common Stock Sale -$7.03K -11 -0.05% $639.52 23.2K Nov 1, 2021 Direct F1, F3
transaction REGN Common Stock Sale -$10.9K -17 -0.07% $640.08 23.2K Nov 1, 2021 Direct F1, F4
transaction REGN Common Stock Sale -$12.2K -19 -0.08% $641.52 23.1K Nov 1, 2021 Direct F1, F5
transaction REGN Common Stock Sale -$5.78K -9 -0.04% $642.28 23.1K Nov 1, 2021 Direct F1, F6
transaction REGN Common Stock Sale -$644 -1 0% $643.82 23.1K Nov 1, 2021 Direct F1
transaction REGN Common Stock Sale -$5.8K -9 -0.04% $644.62 23.1K Nov 1, 2021 Direct F1, F7
transaction REGN Common Stock Sale -$9.68K -15 -0.06% $645.41 23.1K Nov 1, 2021 Direct F1, F8
transaction REGN Common Stock Sale -$3.23K -5 -0.02% $646.37 23.1K Nov 1, 2021 Direct F1, F9
transaction REGN Common Stock Sale -$5.18K -8 -0.03% $647.00 23.1K Nov 1, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 6 shares of Company stock on November 1, 2021 at prices ranging from $638.57 to $638.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F3 Represents volume-weighted average price of sales of 11 shares of Company stock on November 1, 2021 at prices ranging from $639.17 to $639.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 17 shares of Company stock on November 1, 2021 at prices ranging from $640.00 to $640.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 19 shares of Company stock on November 1, 2021 at prices ranging from $641.11 to $641.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 9 shares of Company stock on November 1, 2021 at prices ranging from $642.00 to $642.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 9 shares of Company stock on November 1, 2021 at prices ranging from $644.21 to $644.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 15 shares of Company stock on November 1, 2021 at prices ranging from $645.01 to $645.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.
F9 Represents volume-weighted average price of sales of 5 shares of Company stock on November 1, 2021 at prices ranging from $646.00 to $646.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2021 at each separate price.